跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VILDAGLIPTINA/METFORMINA OLPHA 50 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VILDAGLIPTINA/METFORMINA OLPHA 50 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
VILDAGLIPTINA/METFORMINA OLPHA 50 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Olpha As
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 27, 2024
Approval ID
c49db980cd5bbbc5
Company
Olpha As
Type
Standard
Approval Details
Approval Id
c49db980cd5bbbc5
Drug Cima Aemps Name
VILDAGLIPTINA/METFORMINA OLPHA 50 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
90040
Holder Company Name
Olpha As
Marketing Company Name
Olpha As
Authorization Date
2024-12-27
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
50 mg/1.000 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Olpha As
Active Ingredients
VILDAGLIPTINA
50 mg
METFORMINA HIDROCLORURO
1.000 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 27, 2024
Approval ID
c49db980cd5bbbc5
Type
Standard
Back to CIMA-AEMPS Approvals